semaglutide 3 month weight loss Semaglutide: A Clinician's 2026 Guide
Description
Obesity (2012) 20:156671
Developed by Eli Lilly, retatrutide is a triple hormone receptor agonist (GLP-1, GIP and glucagon)
Many users find success with protein-forward meal planning, front-loading protein early in meals, and using protein supplements when whole food intake falls short
An increased BMI is associated with heightened risks of type 2 diabetes, cardiovascular problems, and certain types of cancer
